This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bader, A. G. Articles by Vogt, P. K. Search for Related Content PubMed PubMed Citation Articles by Bader, A. G. Articles by Vogt, P. K.

Inhibition of Protein Synthesis by Y Box-Binding Protein 1 Blocks Oncogenic Cell Transformation

Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California¹

Received 12 October 2004/ Returned for modification 16 November 2004/ Accepted 17 December 2004

The multifunctional Y box-binding protein 1 (YB-1) is transcriptionally repressed by the oncogenic phosphoinositide 3-kinase (PI3K) pathway (with P3K as an oncogenic homolog of the catalytic subunit) and, when reexpressed with the retroviral vector RCAS, interferes with P3K- and Akt-induced transformation of chicken embryo fibroblasts. Retrovirally expressed YB-1 binds to the cap of mRNAs and inhibits cap-dependent and cap-independent translation. To determine the requirements for the inhibitory role of YB-1 in P3K-induced transformation, we conducted a mutational analysis, measuring YB-1-induced interference with transformation, subcellular localization, cap binding, mRNA binding, homodimerization, and inhibition of translation. The results show that (i) interference with transformation requires RNA binding and a C-terminal domain that is distinct from the cytoplasmic retention domain, (ii) interference with transformation is tightly correlated with inhibition of translation, and (iii) masking of mRNAs by YB-1 is not sufficient to block transformation or to inhibit translation. We identified a noncanonical nuclear localization signal (NLS) in the C-terminal half of YB-1. A mutant lacking the NLS retains its ability to interfere with transformation, indicating that a nuclear function is not required. These results suggest that YB-1 interferes with P3K-induced transformation by a specific inhibition of translation through its RNA-binding domain and a region in the C-terminal domain. Potential functions of the C-terminal region are discussed.

This is manuscript no. 16934-MEM of The Scripps Research Institute.

This article has been cited by other articles:

• Yang, W.-H., Bloch, D. B. (2007). Probing the mRNA processing body using protein macroarrays and "autoantigenomics". RNA 13: 704-712 [Abstract] [Full Text]  
• Roberts, J., Scott, A. C., Howard, M. R., Breen, G., Bubb, V. J., Klenova, E., Quinn, J. P. (2007). Differential Regulation of the Serotonin Transporter Gene by Lithium Is Mediated by Transcription Factors, CCCTC Binding Protein and Y-Box Binding Protein 1, through the Polymorphic Intron 2 Variable Number Tandem Repeat. J. Neurosci. 27: 2793-2801 [Abstract] [Full Text]  
• Uchiumi, T., Fotovati, A., Sasaguri, T., Shibahara, K., Shimada, T., Fukuda, T., Nakamura, T., Izumi, H., Tsuzuki, T., Kuwano, M., Kohno, K. (2006). YB-1 Is Important for an Early Stage Embryonic Development: NEURAL TUBE FORMATION AND CELL PROLIFERATION. J. Biol. Chem. 281: 40440-40449 [Abstract] [Full Text]  
• Lu, Z. H., Books, J. T., Ley, T. J. (2006). Cold Shock Domain Family Members YB-1 and MSY4 Share Essential Functions during Murine Embryogenesis. Mol. Cell. Biol. 26: 8410-8417 [Abstract] [Full Text]  
• Bader, A. G., Kang, S., Vogt, P. K. (2006). Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proc. Natl. Acad. Sci. USA 103: 1475-1479 [Abstract] [Full Text]  
• Evdokimova, V., Ruzanov, P., Anglesio, M. S., Sorokin, A. V., Ovchinnikov, L. P., Buckley, J., Triche, T. J., Sonenberg, N., Sorensen, P. H. B. (2006). Akt-Mediated YB-1 Phosphorylation Activates Translation of Silent mRNA Species. Mol. Cell. Biol. 26: 277-292 [Abstract] [Full Text]